SugenTech Inc
KOSDAQ:253840
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
4 985
8 780
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| KR |
S
|
SugenTech Inc
KOSDAQ:253840
|
91B KRW |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
187.7B USD |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
184.6B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
135.6B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
134.5B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
128.9B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
57B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
48.1B EUR |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
55.8B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.5B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
36.6B USD |
Loading...
|
Market Distribution
| Min | -163 055.6% |
| 30th Percentile | -2.2% |
| Median | 2.7% |
| 70th Percentile | 6.8% |
| Max | 22 874.8% |
Other Profitability Ratios
SugenTech Inc
Glance View
Sugentech, Inc. develops in-vitro diagnostic systems and products. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2016-11-11. The firm is involved in the manufacturing and sale of in vitro diagnostic test reagents, point-of-care testing (POCT) products, folic acid products under the name of SOLGAR, as well as molecular diagnostic reagents. The in vitro diagnostic test reagents are for personal use and are sold under the name SUREARLY. The POCT products are for professional use and are sold under the name INCLIX. In addition, the Company is engaged in therapeutic drug monitoring, as well as drug analysis method development. The firm distributes its products within the domestic market and to overseas markets, including Indonesia.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for SugenTech Inc is -237.1%, which is above its 3-year median of -240.9%.
Over the last 3 years, SugenTech Inc’s Operating Margin has decreased from 49.5% to -237.1%. During this period, it reached a low of -635.7% on Sep 30, 2023 and a high of 49.5% on Aug 30, 2022.